RESEARCH STATS
POOL
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
Interactions with Platform & by Email
PARTICIPANTS
Unique # Participated
VALIDATIONS
Responses Validated*
DATA ROOM
EXECUTIVE
CITATIONS
COMPANY
DISCUSSIONS
BRAND/PRODUCT
INSIGHTS
TOTAL
DATA STACK
*Clients have full access to our data room
DATE
SEP 2023
COMPANIES
152
TABLES
132
PAGES
453
EDITION
18
PRICE
USD 5800
CODE
MCP-1534
*Engagement stats are ongoing and dynamic
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- $500/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- $1000/Month/User. Extra Users @ $100/Month/User
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- $2500/Month/User. Extra Users @ $150/Month/User
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
What`s New?
» Special discussions on the global economic climate and market sentiment
» Coverage on global competitiveness and key competitor percentage market shares
» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass™ research platform
» Complimentary updates for one year
» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Economic Outlook
The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.
The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Contract Research Outsourcing Market to Reach $90.4 Billion by 2030
The global market for Contract Research Outsourcing estimated at US$49.8 Billion in the year 2022, is projected to reach a revised size of US$90.4 Billion by 2030, growing at aCAGR of 7.7% over the period 2022-2030. Clinical, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$61.2 Billion by the end of the analysis period. Growth in the Discovery segment is estimated at 6.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $20.1 Billion, While China is Forecast to Grow at 10.1% CAGR
The Contract Research Outsourcing market in the U.S. is estimated at US$20.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.
SELECT PLAYERS
Charles River Laboratories International, Inc.; Galapagos NV; Albany Molecular Research, Inc.; Axxam SpA; Cyprotex Limited; BioClinica; HD Biosciences Co., Ltd.; Clinipace Inc.; CMIC Holdings Co., Ltd.; EAG Laboratories; Envigo, Inc.; Genoway S.A.; EPS International Co., Ltd.; GenScript Biotech Corporation; Absorption Systems LLC
SEGMENTS
» Service Type (Clinical, Discovery, Pre-Clinical, Laboratory Services) » End-Use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » India » Rest of Asia-Pacific » Latin America » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
COVID-19 Delivers Mixed Results for Pharmaceutical Research Outsourcing Industry |
Players Focus on Collaborative Approach |
Optimism Reigns in Latter Part of 2020 |
COVID-19 and Implications for Drug Development Regulations & Processes |
Opportunities in COVID-19 Programs |
Parallel Gains for Development & Manufacturing |
Contract Research Outsourcing – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Contract Research Outsourcing: An Introduction |
Key Service Markets |
Market Dynamics |
Key Therapeutic Areas of Clinical Trial Research |
EXHIBIT: Global Clinical Trial Services Market by Therapeutic Area: 2019 |
Cost Savings Hold Relevance |
Product Innovations & Enhanced Speed |
Access to Expertise & Sophisticated Technology |
Outlook |
Regional Market Analysis |
Future Model of CRO |
COMPETITIVE SCENARIO |
CRO: A Highly Fragmented Market |
EXHIBIT: Leading Players in the Global Contract Research Outsourcing Market (2019): Percentage Breakdown of Revenues by Player |
Partnership Models Pay Returns |
Strategies and Tactical Programs |
Large CROs Seek the Inorganic Growth Route |
Key Opportunities for CROs |
Technological Superiority: An Advantage |
Consolidation to Gain Pace |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Uptrend in Advanced Medicine Concepts Favors Growth |
Drug Developers Bet on CROs to Sail through Challenging Aspects |
Pharmaceutical & Biopharmaceutical Firms Target Outsourcing |
Gene Therapy Offers Exciting Opportunities for CROs |
COVID-19 Creates a Pause in Gene Therapy Market Growth |
Gene Therapy Set to Witness Rapid Growth Post COVID-19 |
EXHIBIT: Global Gene Therapy Market in US$ Million for Years 2020, 2022, 2024, 2026 |
Increasing Significance of Biologic Drugs Supports Market Demand |
EXHIBIT: Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025 |
COVID-19 Drives Strong Gains for Biologics Activity |
Opportunities Rife in Early Stage Drug Development |
Notable Trends in Pharma/Biopharma R&D Impacting CROs |
Advances in Digital/Technology and its Impact on Clinical Development |
Significant Strides Taken in the Sphere of Current Clinical Research |
Data Quality Oversight (DQO) Undergoes Change |
Pharmacovigilance Set to Grow |
Artificial Intelligence and Machine Learning Gain Interest |
Orphan Drugs to the Fore |
CROs Adapt New Technologies to See More Business in Future |
Streamlining Development of Novel Trial Designs |
Industry Witnesses Increased Spend on R&D Outsourcing |
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025 |
EXHIBIT: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2019 |
Focus on Enhancing Site Selection and Patient Enrollment |
CROs Enter into Alliances to Improve Efficiencies |
Adoption of Digital Technologies Gains Pace |
Toxicology Services Gain Notable Attention |
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery |
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration |
EXHIBIT: Global Biopharma % R&D Outsourcing (2014-2022) |
EXHIBIT: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals |
eClinical Solutions Gain Traction |
Other Noteworthy Market Trends |
Challenges Faced by Contract Research Organizations |
Surging Global Population Offers Increased Growth Opportunities |
EXHIBIT: World Population (in Thousands) by Geographic Region for the Years 2018, 2025, 2040, 2050 |
Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth |
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 |
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
EXHIBIT: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) |
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others |
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045) |
Increasing Healthcare Expenditure and Demand for Generics to Drive Growth |
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
EXHIBIT Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023 |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Contract Research Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Laboratory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Laboratory Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Pharmaceutical & Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030 |
World Contract Research Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
Market Overview |
COVID-19 Pandemic: Mixed Bag of Opportunities for CROs |
Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings |
Trial Services Witness Strong Demand |
High Demand for Data Management Services |
Risk-based Monitoring Catches Pace |
Market Analytics |
USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
JAPAN |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
CHINA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
Market Overview |
China Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
EUROPE |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Market Overview |
Amid Pandemic, CRO Industry in Europe Gears Up for Broad-based Amendments |
Providers Expand Services in Downstream Drug Development |
Market Analytics |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
FRANCE |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
GERMANY |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Spain Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Spain Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Spain 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Russia Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Russia Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Russia 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Market Overview |
Asia-Pacific to Push Up Volume Share in CRO Market |
R&D Outsourcing in Life Sciences on Rise |
Market Analytics |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Value Revenues for India and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
INDIA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E) |
Indian CROs Seek Opportunities |
India Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
India Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
India 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
India Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
India Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
India 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
REST OF ASIA-PACIFIC |
Market Overview |
Australia: Popular Destination for Early Phase Clinical Trials |
Market Analytics |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Asia-Pacific Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Asia-Pacific 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
LATIN AMERICA |
Contract Research Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E) |
Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Latin America Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Latin America Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Latin America 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Contract Research Outsourcing by Service Type - Clinical, Discovery, Pre-Clinical and Laboratory Services Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Value Revenues for Clinical, Discovery, Pre-Clinical and Laboratory Services for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Contract Research Outsourcing by End-Use - Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Contract Research Outsourcing by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.